← SynDRA
DROXICAM
SynDRA canonical compound SYN0023769 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Primary target(s) | PTGS1 | PTGS2 |
|---|
| Mechanism of action | cyclooxygenase inhibitor |
|---|
| Indication | osteoarthritis | rheumatoid arthritis |
|---|
| Disease area | rheumatology |
|---|
All known targets
Mechanisms of action (all sources)
- cyclooxygenase inhibitor
- PTGS2 INHIBITOR
- PTGS1 INHIBITOR
- PTGS1 MODULATOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Drug classes
- Analgesics
- Analgesics, Non-Narcotic
- Anti-Inflammatory Agents
- Anti-Inflammatory Agents, Non-Steroidal
- Antirheumatic Agents
- Peripheral Nervous System Agents
- Sensory System Agents
- Cyclooxygenase Inhibitors
- Enzyme Inhibitors
- Nonsteroidal Anti-inflammatory Drug
ATC classes
- M01A · ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS
- M02A · TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN
- S01B · ANTIINFLAMMATORY AGENTS
Cross-references
Synonyms
- dobenam
- droxar
- ombolan
- Dobenam
- Drogelon
- Droxar
- Ferpan
- Ombolan
- Precam
- E-3128
- E-318
- Droxicamum
- F24ADO1E2D
- CHEBI:76133
- RefChem:135847
- DTXCID90160526
- M01AC04
- Droxicam [INN]
- C16H11N3O5S
- MFCD00866032
- Droxicam (INN)
- Droxicamum [Latin]
- precam
- UNII-F24ADO1E2D
- BRN 6006252
- E 318
- OEHFRZLKGRKFAS-UHFFFAOYSA-N
- DROXICAM [MI]
- DROXICAM [MART.]
- DROXICAM [WHO-DD]
- SCHEMBL24974
- MLS006010209
- orb1305115
- SCHEMBL30396186
- AKOS016014050
- GS-3100
- SMR004701304
- DB-057183
Reported adverse events
- Bleeding
- GI bleed
- Perforation
- Ulceration
- Elderly
- Alopecia
- Anxiety
- Asthma
- Conjunctivitis
- Dizziness
- Hypersensitivity
- Pruritus
Look up DROXICAM in the interactive SynDRA portal →